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Abstract
Background: We investigated the pathological and diagnostic role of selected markers of inflammation, oxidant/
antioxidant status, and cellular injury in human Chagas disease.
Methods: Seropositive/chagasic subjects characterized as clinically-symptomatic or clinically-asymptomatic (n = 116),
seronegative/cardiac subjects (n = 102), and seronegative/healthy subjects (n = 45) were analyzed for peripheral blood
biomarkers.
Results: Seropositive/chagasic subjects exhibited an increase in sera or plasma levels of myeloperoxidase (MPO, 2.8-fold),
advanced oxidation protein products (AOPP, 56%), nitrite (5.7-fold), lipid peroxides (LPO, 12–17-fold) and malondialdehyde
(MDA, 4–6-fold); and a decline in superoxide dismutase (SOD, 52%) and glutathione (GSH, 75%) contents. Correlation
analysis identified a significant (p,0.001) linear relationship between inflammatory markers (AOPP/nitrite: r = 0.877),
inflammation and antioxidant/oxidant status (AOPP/glutathione peroxidase (GPX): r = 0.902, AOPP/GSH: r = 0.806, Nitrite/
GPX: 0.773, Nitrite/LPO: 0.805, MDA/MPO: 0.718), and antioxidant/oxidant levels (GPX/MDA: r = 0.768) in chagasic subjects.
Of these, MPO, LPO and nitrite biomarkers were highly specific and sensitive for distinguishing seropositive/chagasic
subjects from seronegative/healthy controls (p,0.001, training and fitting AUC/ROC .0.95). The MPO (r = 0.664) and LPO
(r = 0.841) levels were also correlated with clinical disease state in chagasic subjects (p,0.001). Seronegative/cardiac
subjects exhibited up to 77% decline in SOD, 3–5-fold increase in LPO and glutamate pyruvate transaminase (GPT) levels,
and statistically insignificant change in MPO, AOPP, MDA, GPX, GSH, and creatine kinase (CK) levels.
Conclusions: The interlinked effects of innate immune responses and antioxidant/oxidant imbalance are major
determinants of human Chagas disease. The MPO, LPO and nitrite are excellent biomarkers for diagnosing seropositive/
chagasic subjects, and MPO and LPO levels have potential utility in identifying clinical severity of Chagas disease.
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Introduction
Trypanosoma cruzi (Tc) is the etiologic agent of Chagas disease.
Acute infection of Tc is clinically unapparent and silent. Most
(.95%) acutely-infected individuals enter a clinically-asymptom-
atic phase defined by positive serological and parasitological tests,
and the absence of cardiac abnormalities [1]. Approximately 30%
of the infected individuals, several years after initial exposure,
develop clinically-symptomatic disease with evidence of cardio-
megaly, ventricular dilation and arrhythmia, leading to heart
failure [2].
Because acute Tc infection is not clinically apparent, it is difficult
to study the role of innate immune cells in mediating parasite
control in human infection. A few studies have suggested that
macrophages, neutrophils and natural killer cells control parasite
replication in the early stages of human infection [3–4].
Experimental studies indicate that Tc-derived molecules engage
toll-like receptors to drive activation of macrophages and
PLOS Neglected Tropical Diseases | www.plosntds.org 1 August 2013 | Volume 7 | Issue 8 | e2364
neutrophils that then produce oxidative burst [5], nitric oxide
(NNO), and HOCl supported by activation of NADPH oxidase,
inducible nitric oxide synthase (iNOS) [6–7], and MPO [8],
respectively. Depletion of neutrophils in murine models of
infection exacerbated disease associated with splenic decline in
expression of Th1 cytokines [9]. Thus, the significance of innate
immune cells in control of Tc-infection is recognized. Others have
noted infiltration of neutrophils and macrophages in chronic
myocardium [10–12], though their role in Chagas disease is not
clear.
Mitochondrial oxidative dysfunction resulting in increased
release of electrons to O2 serves as a main source of superoxide
generation and oxidative stress in chagasic myocardium [13–14].
The byproducts of reactive oxygen species (ROS) and reactive
nitrogen species (RNS) are highly stable, and can cause oxidation
of proteins, lipids, and DNA, leading to deterioration of cellular
structure and function. The sustained oxidative damage, evi-
denced by consistent increase in myocardial protein carbonylation
and MDA contents [15–16], in chagasic hearts occurred not only
due to increased free radical generation, but was also exacerbated
by inefficient antioxidant capacity [17].
In this study, our primary objective was to investigate the
diagnostic efficacy of the markers of inflammation, oxidative stress,
and antioxidant status in identifying Tc-infection and severity of
Chagas disease. For this, we evaluated the oxidative biomarkers
(MDA, LPO), inflammatory mediators (MPO, AOPP, and nitrite);
and antioxidants (GSH, SOD, GPX) in sera and plasma of
seronegative/healthy controls and seropositive/chagasic subjects.
Further, we examined the GPT and CK activities as biomarkers of
cellular injury. Our second objective was to determine whether
sera or plasma serve as a better source, and if sample storage
affects the estimation of the selected biomarkers. Finally, statistical
analysis was performed to identify the correlation between
biomarkers and/or clinical disease state in seropositive/chagasic
subjects. We analyzed plasma samples from seronegative/cardiac
subjects to determine if the selected biomarkers are specific to
chagasic disease or are general indicators of cardiac involvement.
Materials and Methods
Human samples
All procedures were approved by the Institutional Review
Boards at UTMB, Galveston and Universidad Nacional de
Salta (UNSa), Argentina. Human sera samples used in this
study were obtained from Salta Argentina (located at the
border of Bolivia) known to be endemic for T. cruzi
transmission and human infection. Sera samples from seroneg-
ative, healthy individuals and seronegative individuals exhib-
iting cardiac disease of other etiologies were obtained from the
same geographical area in Argentina as well as from UTMB
clinics, and were used as controls. All samples were decoded
and de-identified before they were provided for research
purposes. Written informed consent was obtained from all
individuals. Subjects with co-morbid diseases, e.g., HIV/AIDS,
Leishmaniasis, autoimmune disorders, or chronic hepatic, renal
or pulmonary disease were excluded. Patients’ detailed
information is presented in Table 1.
Table 1. Characterization of the subjects included in the study.
Clinical characterization Enrolled subjects (numbers) Age in years (mean ± SD) Sex Males (%)
Salta, Argentinaa
Seropositive for T. cruzi-specific antibodies
Chagasic 0 n = 54 51.367.6 47 (40%)
Chagasic 1 n = 30 47.6612 15 (50%)
Chagasic 2 n = 17 53.6612.9 10 (55%)
Chagasic 3 n = 15 52.368.2 5 (33%)
Seronegative for T. cruzi-specific antibodies
Healthy, no disease n = 20 35616.2 9 (45%)
Non-endemic areab
Seronegative, healthy, no disease n = 25 39614.7 10 (40%)
Seronegative, other Cardiomyopathy n = 102 59618.2 61 (60%)
aSubjects were screened for T. cruzi-specific antibodies by Wiener Chagatest-ELISA and Wiener Chagatest-HAI kits. Clinical exam included physical exam,
electrocardiography and echocardiography.
bSeronegative subjects from non-endemic areas were screened for T. cruzi-specific antibody response. Seronegative/cardiac patients exhibiting clinical symptoms were
identified based upon blood levels of NT-proBNP to be .2000 pg/ml (normal ,450 pg/ml).
doi:10.1371/journal.pntd.0002364.t001
Author Summary
Chagas disease is a chronic disease of the heart, and
caused by Trypanosoma cruzi infection. In this study, we
have monitored the biomarkers of inflammation caused by
innate immune cells, oxidative stress, and antioxidant
status in seropositive/chagasic, seronegative/cardiac dis-
ease, and seronegative/healthy subjects. Our goal was to
evaluate the diagnostic efficacy of selected biomarkers,
and determine if any of the biomarkers are good indicators
of clinical severity of Chagas disease. We also determined
whether sera or plasma serve as a better source, and if
sample storage affects the estimation of the selected
biomarkers. Our data suggest that innate immune
responses and antioxidant/oxidant imbalance are inter-
linked pathological events in Chagas disease. We have
identified peripheral blood markers (myeloperoxidase,
lipid hydroperoxides and nitrite) that strongly distinguish
seropositive/chagasic subjects from controls. Further, we
found that myeloperoxidase and lipid hydroperoxide levels
have potential utility in identifying seropositive subjects at
risk of developing clinically symptomatic disease.
Biomarkers of Chagas Disease
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Blood samples were collected with K3EDTA (1.5-mg/ml blood)
or without anticoagulant to obtain plasma and serum, respectively.
Tc-specific antibodies in sera samples were monitored by an
enzyme-linked immunosorbent assay using a Wiener Chagatest-
ELISA recombinant v.4.0 kit comprising six recombinant proteins
known to be expressed in mammalian stage of T. cruzi in isolates
circulating in Latin America. Briefly, 96-well plates were coated
with recombinant proteins, and then sequentially incubated with
20-ml sera samples (1:20 dilution), HRP-conjugated human
monoclonal anti-IgG, and color developed with chromogenic
substrate monitored by spectrometry at 450 nm (cut-off value:
average of seronegative samples (,0.1 O.D.)+0.2 O.D., i.e. $0.3).
Serological tests were also done following the specifications of the
commercial IHA test kit (Wiener Chagatest-HAI). Briefly, sera
samples (25-ml 4-fold dilutions) were mixed with red blood cells
sensitized with T. cruzi cytoplasmic and membrane antigens, and
agglutination monitored. The titer was defined as the highest
serum dilution presenting agglutination (positive $1:16 dilution).
Those positive by both tests were identified as seropositive [18].
Cardiologists with .30 years of cumulative experience in
diagnosis and treatment of cardiomyopathy patients of all
etiologies performed the clinical characterization. Clinical data
included medical history, physical examination and subjective
complaint of frequency and severity of exertional dyspnea.
Electrocardiography (12-lead at rest and 3-lead with exercise)
was obtained to identify heart rate variability, ventricular
arrhythmia, atrial- and ventricular-conduction defects, bundle
branch block, and S-T segment and T wave changes. Transtho-
racic echocardiography is one of the most important diagnostic
procedures to obtain objective information regarding the left
ventricular (LV) contractile function. The following routine 2D
and Doppler echo were evaluated: 1) end systolic and end-diastolic
LV dimensions, 2) mitral inflow pattern, and 3) pulmonary vein
flow pattern. LV ejection fraction (LVEF) was used to represent
LV systolic function. LV diastolic function was assessed based on
Doppler mitral inflow patterns and Doppler pulmonary venous
flow patterns, and the severity of diastolic dysfunction graded as I–
IV [19]. Global/regional wall-motion abnormalities and inter-
cavity thrombus were also recorded. Seronegative/healthy sub-
jects (n = 45) exhibiting no history or clinical symptoms of heart
disease were used as controls. Seropositive/chagasic patients
(n = 116) were classified based on clinical exam as follows: CD0:
no echocardiography abnormalities, no left ventricular dilatations,
and $70% ejection fraction (EF) indicating preserved systolic
function, CD1: negligible to minor EKG alterations, EF: 55–70%,
no indication of heart involvement; CD2: a degree of heart
involvement with systolic dysfunction (EF: 40–55%); and CD3:
moderate to severe systolic dysfunction (EF#40%), left ventricular
dilatation (diastolic diameter $57 mm), and/or potential signs of
congestive heart failure. For the statistical analysis purpose,
chagasic subjects in CD0–CD1 and CD2–CD3 clinical state were
classified as clinically asymptomatic and clinically symptomatic,
respectively. Seronegative subjects with ischemic or non-ischemic
cardiovascular involvement (n = 102) were identified based upon
clinical exam, and blood levels of NT-proBNP .2000 ng/ml that
reflects NYHA classification II–III of cardiac involvement (similar
to CD2–CD3 chagasic group). All assays were conducted in 96-
well format.
Inflammatory markers
MPO activity was determined by a dianisidine-H2O2 method
[20]. Briefly, samples (10 ml) were added to 0.53 mM o-dianisidine
dihydrochloride (Sigma-Aldrich) and 0.15 mM H2O2 in 50 mM
K2HPO4 buffer (pH 6.0), and absorbance recorded at 460 nm on
a SpectraMax 190 microplate reader (Molecular Devices). Sample
protein content was measured by Bradford method, and 1 unit
MPO was defined as that degrading 1 nmol H2O2/min at 25uC
(e=11300 M21.cm21).
Dityrosine-containing protein cross-linking products, designated
as AOPP, are the products of HOCl-induced chlorination of
amines. Samples (20 ml/well) were mixed with 10 ml of 1.16 M KI
and 20 ml of 100% acetic acid (final volume: 200 ml). Absorbance
was recorded at 340 nm, and AOPP concentration expressed as
chloramine-T equivalents (standard curve: 0–100 mmol chlora-
mine-T/ml) [21].
The NNO level (indicator of iNOS activity), was monitored by
using Nitrate/nitrite Assay Kit (Cayman). Briefly, samples (10 mg
protein) were reduced with 0.01 unit/100 ml of nitrite reductase,
and incubated for 10 min with 100 ml of 1% sulfanilamide made
in 5% phosphoric acid/0.1% N-(1-napthyl) ethylenediamine
dihydrochloride (1:1,v/v). Formation of diazonium salt was
monitored at 545 nm (standard curve: 2–50 mM sodium nitrite).
Oxidative stress markers
We utilized LPO Assay Kit (Cayman) to measure the lipid
peroxides. Peripheral blood LPOs were extracted into chloroform,
and added to 50 ml of 4.5 mM FeSO4 in 0.2M HCl/3% NH4SCN
in methanol (1:1, v/v). The redox reaction with ferrous ions was
stopped after 5-min, and absorbance monitored at 500 nm
(standard curve: 0–500-mM 13-hydroperoxy octadecadienoic
acid).
MDA level was measured by using the QuantiChrom TBARS
Assay Kit (BioAssay Systems). Samples (10 ml) were suspended in
200 ml thiobarbituric acid (TBA) reagent and heated at 100uC for
60 min. After cooling, the reaction mixture was centrifuged, and
TBARS equivalent in supernatants monitored at 535 nm (stan-
dard curve: 0–30 mM MDA).
Antioxidants
To measure SOD activity, we utilized SOD Assay Kit
(Cayman). Briefly samples (10 ml) were mixed with 50 ml of
reaction mixture), reaction was initiated with xanthine oxidase,
and the reduction of NBT by O2
N2 monitored at 450 nm [22].
One unit of SOD activity was defined as that producing 50%
dismutation of O2
N2 radical.
To measure GPX activity, samples (10 ml) were added to 90 ml
assay buffer (50 mM Tris HCl, 0.5 mM EDTA, pH 7.6)
containing, 2 mM GSH and 100-mU glutathione reductase
(GSR) and 0.15 mM NADPH. GPX catalyzed reduction of
cumene hydroperoxide (0.8 mM) coupled with GSR-dependent
NADPH oxidation was recorded at 340 nm (e=0.00373 mM21)
[23].
For GSH content, 100 ml of the supernatants from the
deproteinated samples were added to 200 ml of assay buffer (0.1
M sodium phosphate, 5 mM EDTA buffer, pH 7.5) containing
0.1M triethanolamine, 0.6 mM 5-59-dithiobis 2-nitrobenzoic acid
(DTNB) and 0.15 mM NADPH. The reaction was initiated with
10 ml GSR (3 U/ml), and the reduction of DTNB by GSH
monitored at 412 nm (standard curve: 0–8 mM GSSG).
Cellular injury markers
GPT catalyzes reversible transamination between alanine and
a-ketoglutarate to form pyruvate and glutamate. Briefly, 5 ml
samples were added to 100 ml assay buffer (100 mM Tris HCl
pH 7.8, 100 mM NaHCO3, 0.1 mM pyridoxal 5-phosphate,
0.01% sodium azide) containing L-alanine, NADH and lactate
dehydrogenase (LDH). The reaction was initiated with addition of
150 mM a-ketoglutarate, and NADH oxidation was recorded at
Biomarkers of Chagas Disease
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340 nm. One unit of GPT converted 1 mmol of a-ketoglutarate to
L-glutamate per minute at 37uC (e=4.11 mM21).
Creatine kinase activity was determined using EnzyChrom CK
Assay Kit (BioAssay Systems). Briefly, samples (5 ml) were mixed
with 100 ml assay buffer, and CK-dependent formation of ATP
was coupled with glucose (20 mM) phosphorylation by hexokinase
(250 units) and subsequent oxidation of glucose-6-phosphate by
NADP (2 mM) in presence of glucose-6-phosphate dehydrogenase,
the resultant NADPH monitored at 340 nm. One unit of CK
activity transferred 1 mmol phosphate/min at pH 6.0 (detection
limit: 5-nU/ml).
Data analysis
All samples were analyzed in triplicate, and data are presented
as mean6S.D. All data were analyzed using SigmaPlot v12. Data
were log transformed and when normally distributed, analyzed by
Student t test (comparison of 2-groups) and 1-way analysis of
variance (ANOVA) with Tukey’s post-hoc test (comparison of
multiple groups). When the data were not normally distributed,
non-parametric tests Mann-Whitney (M-W, comparison of two
groups) and Kruskal-Wallis with Dunn’s method (comparison of
multiple groups) were employed. Significance was accepted at
p,0.05. Pearson’s (normally distributed data variables) and
Spearman’s (non-normally distributed data variables) correlation
analysis were performed to determine the strength of linear
relationship between different parameters. Multivariate Adaptive
Regression Splines (MARS) was employed to model the utility of
inter-relational changes in multiple variables in distinguishing
infection and disease status [24]. The sensitivity and specificity of
the biomarkers was validated by receiver operator characteristics
(ROC) curves.
Results
Inflammatory markers: Sera levels of MPO and plasma
levels of AOPP and nitrite are enhanced in seropositive/
chagasic subjects
Plasma and sera samples from enrolled subjects were stored at
280uC, and thawed when utilized. Summarized data (mean 6
SD and range values) are presented in Table S1. MPO activity,
a marker of neutrophil activation, was increased by 32% and
2.8-fold in plasma and sera, respectively, of seropositive/
chagasic subjects as compared to that noted in seronegative/
healthy and seronegative/cardiac subjects (p,0.001, Fig. 1A&B).
All seropositive subjects exhibited sera MPO activity above the
meanseronegative level, while none of the seronegative/healthy
controls exhibited MPO above the meanseropositive level. MPO
activity was not significantly altered in seronegative/cardiac
subjects (Fig. 1A).
AOPPs are secondary marker of MPO activation. AOPP
contents were increased by 56% and 26% in plasma and sera,
respectively, of seropositive/chagasic subjects as compared to
that noted in seronegative/healthy and seronegative/cardiac
subjects (p,0.001, Fig. 1C&D). All seropositive subjects
exhibited plasma AOPP contents above the meanseronegative
level, while only 2% seronegative/healthy subjects exhibited
AOPP contents above the meanseropositive level. AOPP contents
were not significantly altered in plasma of seronegative/cardiac
subjects (Fig. 1C).
Activated macrophages produce iNOS-mediated NNO that is
then reduced to nitrite. Seropositive/chagasic subjects exhibited
a 5.8-fold and 5.2-fold increase in plasma levels of nitrite
content when compared to that noted in plasma of seronega-
tive/healthy and seronegative/cardiac subjects, respectively
(p,0.001, Fig. 1E). Sera level of nitrite content was increased
by 39% in seropositive/chagasic subjects (p,0.05, Fig. 1F). All
seropositive subjects exhibited plasma nitrite contents above the
meanseronegative level while none of the seronegative/healthy
subjects exhibited plasma nitrite contents above the mean-
seropositive level. Plasma nitrite contents were marginally in-
creased in seronegative/cardiac subjects when compared to the
seronegative/healthy controls (Fig. 1E). Together, the data
presented in Fig. 1 suggested that a) neutrophil (MPO) and
macrophage (iNOS) activation contributed to inflammatory
state in seropositive/chagasic subjects, and MPO activation
resulted in the formation of deleterious oxidants. Sera were
useful for monitoring the MPO activity, and plasma for
Figure 1. Neutrophil (MPO) and macrophage (iNOS) activation
indicate inflammatory state of seropositive/chagasic subjects.
Plasma and sera samples were obtained from seronegative/healthy (SN/
H), seropositive/chagasic (SP/C) and seronegative/cardiac (SN/C)
subjects, as described in Materials and Methods. Shown are the plasma
(A,C,E) and sera (B,D,F) levels of MPO activity (A&B), AOPP contents
(C&D) and nitrite levels (E&F). For all figures, data (mean of triplicate
observations from each sample) are presented as box plot. The
horizontal lines of the box (bottom to top) depict the lower quartile
(Q1, cuts off lowest 25% of the data), median (Q2, middle value), and
upper quartile (Q3, cuts off the highest 25% of the data). The lower and
upper whiskers depict the smallest and largest non-outlier observa-
tions, respectively, and solid dots represent the outliers. The spacing
between the different parts of the box indicates the degree of
dispersion (spread). Standard deviation for triplicate observations for all
samples was ,12%. Significance is shown as *p,0.05, **p,0.05, and
***p,0.001.
doi:10.1371/journal.pntd.0002364.g001
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analyzing AOPP level and iNOS activity. The seronegative/
cardiac subjects with cardiac involvement of other etiologies
exhibited very low to no changes in inflammatory markers.
LPO and MDA are indicators of oxidative stress in Chagas
disease
LPO refers to highly reactive hydroperoxides of saturated and
unsaturated lipids, formed by oxidation. Plasma and sera levels of
LPO were increased by 17-fold and 11.7-fold, respectively, in
seropositive/chagasic subjects as compared to the seronegative/
healthy controls (Fig. 2A&B, p,0.001). More than 97% of
seropositive subjects had LPO level above the meanseronegative level,
while ,2% seronegative/healthy subjects exhibited LPO above
the meanseropositive level. Seronegative/cardiac subjects also
exhibited an increase in plasma LPO levels (up to 5-fold) when
compared to the seronegative/healthy controls (Fig. 2A, p,0.01);
however, the extent of increase in plasma LPO in seronegative/
cardiac subjects was significantly lower than that noted in
seropositive/chagasic subjects (Fig. 2A, p,0.01).
MDA are most stable breakdown products of LPO. Seropos-
itive/chagasic subjects exhibited a 3.7-fold and 6.2-fold increase in
plasma levels of MDA when compared to that noted in plasma of
seronegative/healthy and seronegative/cardiac subjects, respec-
tively (p,0.01-0.001, Fig. 2C). Sera level of MDA content was
increased by 6-fold in seropositive/chagasic subjects (p,0.001,
Fig. 2D). More than 91% of seropositive/chagasic subjects
exhibited plasma and sera MDA levels above the meanseronegative
level, while none of the seronegative/healthy subjects exhibited
MDA contents above the meanseropositive level. The MDA level was
not significantly changed in seronegative/cardiac subjects (Fig. 2C).
These data showed that both sera and plasma are good source of
samples for monitoring LPO and MDA levels, and oxidative stress
induced damage is significantly increased in seropositive chagasic
subjects.
Antioxidants: Plasma levels of SOD and GSH are
decreased in chagasic subjects
We examined the activities of SOD and GPX enzymes and
GSH content, these being the important members of the
antioxidant defense system. SOD catalyzes dismutation of O2
N2
to H2O2 which is reduced to H2O and O2 by GPX using GSH.
The plasma levels of SOD activity was decreased by .2-fold in
seropositive/chagasic and seronegative/cardiac subjects when
compared to that noted in seronegative/healthy controls (Fig. 3A,
p,0.01-0.001). More than 97% of seropositive subjects exhibited
plasma SOD activity below the meanseronegative level. The plasma
levels of GPX activity was not significantly different among
seropositive/chagasic, seronegative/healthy and seronegative/
cardiac groups (Fig. 3C); however, GSH level was affected in
seropositive subjects. We noted the plasma levels of GSH were
decreased by 4-fold in seropositive/chagasic subjects (Fig. 3E,
p,0.001). More than 94% of the seropositive subjects exhibited
plasma GSH levels at or below the meanseronegative level, while
,20% of the seronegative/healthy subjects exhibited plasma GSH
levels below the meanseropositive level. No significant difference in
sera levels of SOD, GPX and GSH was observed in seropositive
Figure 2. LPO and MDA are biomarkers of increased oxidative
stress in chagasic subjects. The plasma (A&C) and sera (B&D) levels
of lipid hydroperoxides (A&B) and malondialdehyde (C&D) were
measured by spectrophotometry.
doi:10.1371/journal.pntd.0002364.g002
Figure 3. SOD and GSH are indicators of compromised
antioxidant status in chagasic subjects. Plasma (A, C, E) and sera
(B, D, F) levels of activities of the superoxide dismutase (A&B) and
glutathione peroxidase (C&D) were determined by spectrophotometry.
The glutathione contents (E&F) were measured by GSSG-DTNB
recycling assay.
doi:10.1371/journal.pntd.0002364.g003
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versus seronegative groups (Figs. 3B, 3D, 3F). These data suggest
that peripheral antioxidant capacity, measured by plasma levels of
SOD activity and GSH contents, is compromised in chagasic
subjects. The seronegative/cardiac subjects exhibited a significant
decline in plasma levels of SOD activity; however, this decline in
SOD had no effect on overall antioxidant status, evidenced by no
change in GPX and GSH levels.
CK and GPT are not good indicators of tissue injury in
Chagas disease
CK is assayed as a marker of muscle damage in myocardial
infarction. Increased serum level of GPT is often detected in
congestive heart failure. We observed no significant increase in
plasma and sera levels of CK and GPT activities in seropositive/
chagasic subjects as compared to seronegative/healthy controls
(Fig. 4). Seronegative/cardiac subjects exhibited a 3-fold increase
in GPT activity when compared to that detected in normal/
healthy controls or seropositive/chagasic subjects (Fig. 4A,
p,0.01-0.001). These data suggest that traditional risk factors
associated with heart failure are not good indicators of disease
progression in seropositive/chagasic subjects.
Stability of selected biomarkers and field relevance
We analyzed sera and plasma samples subjected to two cycles
of freezing/thawing to determine if the above-studied biomark-
ers withstand temperature variance (Fig. S1). The observed
increase in MPO activity and AOPP contents in freshly-frozen
samples from seropositive subjects (Fig. 1B&C) were not
detectable after freeze/thaw cycles (Fig. S1A&B). Nitrite level
remained increased by 3-fold in seropositive/chagasic plasma
subjected to freeze/thaw cycles (Fig. S1C, p,0.01), similar to
that noted in freshly-frozen samples (Fig. 1E). The LPO and
MDA levels, though decreased when compared to that noted in
freshly-frozen samples (Fig. 2), remained increased by 6-fold and
2-fold, respectively, in seropositive plasma samples subjected to
freeze-thaw cycles (Fig. S1D&E, p,0.001). Likewise, a signif-
icant decline of 70% and 80% in SOD activity and GSH
contents, respectively, was detectable in seropositive/chagasic
plasma samples subjected to freeze-thaw cycles (Fig. S1F&G,
p,0.01). These data suggest that nitrite, LPO, MDA, SOD and
GSH are stable metabolites, and can be employed to examine
inflammatory/oxidative stress and antioxidant status in chagasic
samples that may undergo temperature or storage irregularities
or are collected at the field sites.
Inter-relationship between selected biomarkers
Correlation analysis was performed to identify the strength of
relationship between various biomarkers, and accepted as very
strong with r value of .0.8 and moderately strong with r value of
0.6–0.8 (p,0.01, Table 2). Including data from seronegative/
healthy and seropositive/chagasic subjects in the analysis, we
observed a significant, moderately strong to very strong linear
relationship between sera levels of MPO/AOPP, MPO/LPO,
AOPP/nitrite, AOPP/MDA, nitrite/MDA, and LPO/MDA (all
p,0.001, r$0.600). Within the seropositive/chagasic group only,
a strong relationship was observed for AOPP/nitrite (r = 0.877,
p,0.001), AOPP/MDA (r = 0.711, p,0.001), MPO/SOD
(r = 0.628, p,0.01) and AOPP/GSH (r= 0.806, p,0.001). When
performing correlation analysis of plasma levels of various
biomarkers in seropositive/chagasic subjects, we noted a signifi-
cant, moderately strong linear relationship between MPO/AOPP,
MPO/MDA, MPO/GPX, AOPP/MDA, AOPP/GPX, MDA/
GPX, LPO/SOD, and GPX/GSH (all p,0.001, r$0.600), the
maximum strength being detected for AOPP/GPX (r = 0.886,
p,0.001, Fig. 5A). A strong correlation between MPO/AOPP,
AOPP/MDA and AOPP/GPX was maintained when plasma
samples were subjected to freeze-thaw cycles (all p,0.001,
r = 0.650–0.902). Correlation analysis of sera versus plasma levels
of various parameters, including data from seronegative/healthy
and seropositive/chagasic subjects, identified a very strong linear
relationship between LPO and nitrite (r = 0.805, p,0.001, Fig. 5B)
also. The observation of a strong correlation between increase in
biomarkers of oxidative stress and inflammatory state, and
between increase in oxidative stress (or inflammatory state)
biomarkers and decrease in antioxidants suggest that inflamma-
tory, oxidant and antioxidant responses are interlinked events in
Chagas disease.
MARS analysis was performed to develop a classification model
(Fig. 5C&D). Inputs to the model were the seronegative/healthy
and seropositive/chagasic values for various parameters assessed
in plasma and sera samples. To address the possible issue of over-
fitting the data, we split the data into a training portion (80%) and
a testing portion (20%). The blue curve in the model represents the
fit of the model for the training dataset, i.e., 80% of the data that
was utilized for creating the model; the 20% of the remaining data
was used to assess the fit of the model for testing dataset (red
curve). MARS modeling of the data collected from investigation of
MPO, AOPP, nitrite, MDA, LPO, SOD and GSH in plasma is
presented in Fig. 5C. The prediction success showed the model fits
perfectly on the training data for LPO, nitrite and SOD (AUC/
ROC value of 1.00, blue curve) and excellently on the testing
dataset for LPO, nitrite and SOD (AUC/ROC value of 0.99955,
red curve) (Fig. 5C). MARS modeling of the MPO, LPO, and
nitrite levels in sera samples is shown in Fig. 5D. The prediction
success showed the model fits perfectly on the training data (AUC/
ROC value of 1.00, blue curve), and very well on the testing data
(AUC/ROC value of 0.9589, red curve) for the three variables
(Fig. 5D). These analyses suggest that plasma or sera levels of
MPO, LPO, SOD and nitrite are highly specific and sensitive for
distinguishing seropositive/chagasic subjects from seronegative/
healthy controls, and the model developed based upon these
variables will work well in predicting seropositive/chagasic
patients from seronegative/healthy controls.
Significance of selected biomarkers with respect to
clinical disease state
Lastly, we determined if the studied parameters were associated
with clinical disease status in seropositive/chagasic subjects. The
Kruskal-Wallis/Dunn’s analysis identified the plasma levels of
Figure 4. Metabolic markers of tissue injury were not
significantly altered in chagasic subjects. Shown are plasma
levels of activities of the glutamate pyruvate transaminase (A) and
creatine kinase (B), determined by spectrophotometry.
doi:10.1371/journal.pntd.0002364.g004
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MPO was significantly different between normal/healthy and
CD0–CD1 stage chagasic patients (p,0.005), AOPP was signif-
icantly different between normal/healthy and CD2–CD3 stage
chagasic patients (p,0.049), and nitrite, MDA, LPO, GSH, and
SOD levels significantly distinguished the normal/healthy controls
from CD0–CD1 or CD2–CD3 stages in chagasic subjects (all
p,0.001). The Kruskal-Wallis/Dunn’s analysis of the sera level of
biomarkers with respect to disease category identified the AOPP
and nitrite levels were significantly different between CD0–CD1
and CD2–CD3 stage chagasic patients (p,0.001), and MPO,
MDA, and LPO levels significantly distinguished normal/healthy
from CD0–CD1 and CD2–CD3 stage chagasic subjects (all
p,0.001). None of the observed parameters indicated a significant
difference between seronegative/healthy and seronegative/cardiac
subjects.
Correlation analysis performed on the seronegative/healthy and
seropositive/chagasic subjects suggested a significant, moderately
strong linear relationship of clinical disease category with sera
levels of MPO (r = 0.624, p,0.000, Fig. 5E) and LPO
(r = 0.710, p,0.001, Fig. 5F), and fair correlation of clinical
disease severity with sera levels of MDA (r = 0.512, p,0.001),
AOPP (r = 0.436, p,0.001), and nitrite (r = 0.439, p,0.001).
The plasma level of LPO also exhibited a moderately strong
correlation with the clinical disease category (r = 0.625,
p,0.001). MARS modeling with input of data for all variables
and disease status from 80% of the seropositive/chagasic
subjects showed the model fits on the training data with an
ROC/AUC value of 0.786 for plasma level of LPO and ROC/
AUC value of 0.696 for sera level of MPO. The 20% of the
remaining datasets did not verify the sensitivity/specificity of the
LPO- and MPO-based training model in distinguishing disease
severity in seropositive/chagasic subjects. Together, these data
suggest that selected biomarkers can significantly distinguish
healthy controls from chagasic subjects; and MPO and LPO
Table 2. Correlation analysis.
Parameters
Correlation coefficient
(R value) Significance (p value)
Correlation coefficient
(R value) Significance (p value)
Including data from SN/H and SP/C subjects Including data from SP/C subjects only
Sera/Sera
MPO/AOPP 0.664 0.000 0.608 0.004
MPO/LPO 0.600 0.000 - -
MPO/SOD - - 0.628 0.003
AOPP/Nitrite 0.616 0.000 0.877 0.000
AOPP/MDA 0.634 0.000 0.711 0.000
AOPP/GSH - - 0.806 0.000
Nitrite/MDA 0.698 0.000 0.702 0.001
Nitrite/GSH - - 0.658 0.002
LPO/MDA 0.637 0.000 - -
Plasma/Plasma
MPO/AOPP - - 0.65 0.001
MPO/MDA - - 0.718 0.000
MPO/GPX - - 0.629 0.004
AOPP/MDA - - 0.802 0.000
AOPP/GPX - - 0.886 0.000
MDA/GPX - - 0.768 0.000
LPO/SOD - - 0.602 0.002
GPX/GSH - - 0.600 0.011
Sera/Plasma
MPO/Nitrite 0.65 0.000 ND ND
MDA/Nitrite 0.732 0.000 ND ND
LPO/Nitrite 0.805 0.001 ND ND
Plasma/Plasma (subjected to freeze-thaw cycles)
MPO/AOPP - - 0.650 0.000
AOPP/MDA - - 0.802 0.000
AOPP/GPX - - 0.902 0.000
Nitrite/GPX - - 0.773 0.000
Plasma and sera samples from seronegative/healthy (SN/H, n = 45) and seropositive/chagasic (SP/C, n = 116) subjects were submitted to spectrophotometry analysis of
various biomarkers of inflammation, oxidative stress, antioxidant status and cellular injury as described in Materials and Methods. Pearson’s or Spearman’s analysis was
conducted to evaluate the strength of linear relationship between sera or plasma levels of biomarkers (among themselves) or with clinical disease category. Correlations
coefficient (r) value of .0.8 was considered very strong and that of between 0.6–0.8 accepted as moderately strong [31]. ‘‘-’’indicates a significant correlation at p,0.01
was not present. ND: not determined.
doi:10.1371/journal.pntd.0002364.t002
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might be good indicators of clinical disease category in chagasic
group.
Discussion
In this study, we have investigated the selected biomarkers of
innate immune response, and antioxidant/oxidant status in
seropositive/chagasic and seronegative/cardiac subjects. Our data
clearly show a significant increase in MPO, AOPP, nitrite
(markers of innate immune response), LPO and MDA (markers
of oxidative stress) and a decline in SOD and GSH (markers of
antioxidant status) in seropositive/chagasic subjects. Seronegative/
cardiac subjects exhibited a decline in SOD and a moderate
increase in LPO and GPT levels; however, biomarkers of
inflammation (MPO, AOPP, and nitrite) and MDA were not
changed. Our data allow us to propose that oxidative/inflamma-
tory stress is more pronounced in chagasic subjects with an
infectious etiology, and LPO and MPO are potential biomarkers
for identifying chagasic disease stage. To the best of our
knowledge, this is the first report demonstrating the interlinked
effects of innate responses, antioxidant status and oxidants levels in
Chagas disease (Fig. 6).
Our data suggest that macrophages and neutrophils activation
and formation of cytotoxic molecules (MPO, AOPP, and NNO)
persist in chronic Tc infection (Fig. 1). Our finding of a significant
linear correlation between MPO and clinically-symptomatic
disease provide the first evidence for the pathological significance
of increased MPO activity in Chagas disease, and potential use of
this biomarker in diagnosing disease severity. The stimuli that may
drive the activation of innate immune cells in Chagas disease are
not known. Considering the very low parasite burden in chronic
stage, we believe that damage-associated molecular patterns
(DAMPs) drive the activation of macrophages and neutrophils in
chronic chagasic disease, to be determined in future studies.
A pro-oxidant milieu in seropositive humans has been
demonstrated by increased GSSG/GSH ratio [25–26]. In this
study, detection of 8–10-fold higher serum and plasma levels of
LPO and MDA in seropositive/chagasic subjects, and the
observation that LPO and MDA remained increased in seropos-
itive samples subjected to long-term storage and freeze/thaw
cycles demonstrate that these are stable markers for measuring
oxidative stress in field-setting where immediate freezing of the
freshly-collected samples may not be possible. A strong positive
relationship between LPO levels and clinically-symptomatic
disease suggest the prognostic value of LPO in identifying clinical
disease in chagasic subjects, to be further verified using large-scale
datasets in future studies. Multiple mechanisms are likely to
contribute to increased LPO/MDA contents in chagasic subjects.
One, increased sera/plasma levels of AOPP and NNO in
seropositive/chagasic subjects imply that the cytotoxic effects of
free radicals released by innate immune cells would contribute to
plasma LPO and MDA formation in chagasic subjects. Two,
increase in plasma LPO/MDA levels in seropositive/chagasic
subjects may also be due to oxidatively-modified lipids released as
a consequence of cellular injuries incurred in the cardiac tissue.
This notion is supported by the observation of intense oxidative
modifications of DNA, lipids and proteins in chagasic myocardium
[13,15] and identification of multiple oxidatively-modified cardiac
proteins in sera/plasma of chronically-infected animals [27–28]
and humans [18]. Three, SOD and GPX/GSH antioxidants,
utilized by mammalian cells to cope with free radicals, were
compromised in chagasic myocardium [14,17]. Decreased plasma
levels of GPX in human chagasic subjects has been reported [29].
The observation of decreased SOD activity and GSH contents in
plasma (Fig. 3) and peripheral blood cells of seropositive subjects
[26] provide a strong evidence that human chagasic subjects are
compromised in their capacity to activate antioxidant defense
against oxidative stress. We surmise that increased plasma levels of
MDA and LPO indicate that oxidant/antioxidant balance is
tipped towards oxidative stress-induced damaging responses in
chagasic subjects.
Serum is qualitatively and quantitatively different from plasma
[30]. In serum, the bulk of the fibrinogen is removed by conversion
into a fibrin clot together with the platelets which are either
physically bound in the fibrin matrix or activated to form
aggregates or both. During this process, varying amounts of other
proteins are removed into the fibrin clot either by specific or non-
Figure 5. Pair-wise correlation and modeling analysis. Pair-wise
correlation analysis of (A) nitrite (mmol/mg protein) with LPO (mmol/ml)
and (B) glutathione peroxidase (units/mg protein) with AOPP (mmol/ml)
utilizing data from plasma analysis of seropositive/chagasic and
seronegative/healthy subjects is shown. (C&D) MARS analysis was
performed using 80% of the data for various biomarkers from
seronegative/healthy and seropositive/chagasic subjects as training
dataset (blue curve) and 20% of the remaining data as test dataset to
assess the performance of the model (red curve). Shown in panel C is
MARS analysis of plasma levels of the biomarkers that revealed model
fits perfectly (AUC/ROC = 1) on the training data for LPO, nitrite and
SOD (with AUC/ROC of 0.099955 with testing dataset). Shown in panel
D is MARS analysis of sera levels of the biomarkers that revealed model
fits perfectly (AUC/ROC = 1) on the training data for MPO, LPO, and
nitrite (with AUC/ROC of 0.9589 with testing dataset). (E&F) Shown are
pair-wise correlation analyses of MPO (E) and LPO (F) contents with
clinical disease. Each dot represents an individual subject.
doi:10.1371/journal.pntd.0002364.g005
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specific interactions. Further, in the process of whole blood
coagulation, the cellular elements (erythrocytes, leukocytes,
platelets) can secrete components that are enriched in serum.
For example, platelets contribute a variety of components to blood
serum; e.g., vascular endothelial growth factor (VEGF) is detected
at 250-pg/ml in serum and 30-pg/ml in plasma of healthy
individuals [30]. Our observation of significant differences in
plasma and serum levels of various biomarkers in this study
support the notion that serum and plasma are not inter-
changeable samples, and results derived from serum and plasma
analysis should be carefully documented.
Seronegative/cardiac subjects in our study were categorized in
NYHA functional class of II–III with NT-proBNP levels of
.2000-ng/ml. However, except for a decline in plasma levels of
SOD, and an increase in LPO and GPT levels, these subjects
exhibited no change in other biomarkers that were altered in
seropositive/chagasic subjects. We surmise that antioxidant/
oxidant imbalance and cellular injury, though present, were not
pronounced due to absence of inflammatory stress in seronega-
tive/cardiac subjects.
Correlation coefficient (r) demonstrates the degree of linear
relationship between the two variables. The r value of .0.8, 0.6–
0.8, 0.3–0.5 and ,0.3 are interpreted to exhibit a very strong,
moderately strong, fair and poor linear relationships respectively
[31]. Our data showed a very strong to moderately strong and
significant (p,0.01) linear relationship between inflammatory
markers (AOPP/Nitrate), inflammation and antioxidant status
(AOPP/GPX, AOPP/GSH, Nitrite/GPX), and inflammation and
oxidant status (Nitrite/LPO, MPO/TBARS) in seropositive/
chagasic subjects. Of these, MPO, LPO and nitrite biomarkers
were highly specific and sensitive for distinguishing seropositive/
chagasic subjects from seronegative/healthy controls, evidenced
by MARS modeling of the datasets. The AUC/ROC value of
.0.95 of the testing dataset provides confidence that the model is
not over-fitting the efficacy of MPO, LPO and nitrite in predicting
seropositive/chagasic subjects. These data strongly suggest that
innate immune cell responses and oxidant/antioxidant imbalance
are interlinked and potential determinants of chronic Chagas
disease. What might be the mechanisms linking oxidant/antiox-
idant imbalance and innate immune responses in chagasic disease
are not known; however, the finding of neo-antigens (oxidized host
molecules) as targets of antibody responses [32] and the ability of
antibodies purified from the sera of chronically-infected individ-
uals to trigger proliferative responses in PBMCs [33] provide clues.
We propose that ROS of mitochondrial and inflammatory origin,
coupled with an antioxidants’ decline, leads to cellular oxidative
damage. The intracellular molecules (e.g., DNA, protein, lipids)
that may be released from apoptotic or necrotic cells are
recognized by pattern recognition receptors, signaling activation
of innate immune cells in chronically-infected chagasic subjects.
In summary, our data suggest interlinked effects of innate
immune responses and oxidant/antioxidant imbalance play a
Figure 6. Inter-linked innate immune responses and oxidant/antioxidant status are major determinants of chronic Chagas disease.
Trypanosoma cruzi or danger-associated molecular patterns (DAMPs) released due to cellular injuries stimulate ROS (O2
2N, H2O2,
NOH) production by
(1) NADPH oxidase–dependent oxidative burst in macrophages/monocytes and (2) mitochondrial membrane permeability transition and electron
transport chain (ETC) inefficiency in non-phagocytes (e.g. cardiac myocytes). Likewise, Tc and DAMPs can activate phagocytes/neutrophils resulting in
(3) iNOS-dependent NNO and (4) myeloperoxidase-dependent HOCl production. If these reactive species are not scavenged by (5) activation of
antioxidants (e.g. superoxide dismutases (SOD), glutathione peroxidase (GPX) and glutathione (GSH), then highly stable free radicals, e.g.,
peroxynitrite (NOONO), nitrosyl chloride and AOPPs are formed that (6) further inflict host cellular oxidative damage of lipids (e.g. LPO, MDA). The
intracellular molecules (e.g., DNA, protein, lipids) that may be released from apoptotic or necrotic cells in oxidized form serve as DAMPs, sustaining
the signaling activation of innate immune cells in chronically infected chagasic subjects.
doi:10.1371/journal.pntd.0002364.g006
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major role in chronic phase of Chagas disease. This is evidenced
by finding that increase in biomarkers of innate immune responses
(MPO, AOPP, nitrite), oxidative stress (LPO, MDA) and a decline
in antioxidant response (SOD, GSH, GPX) in seropositive/
chagasic subjects was strongly correlated. We propose that a
substantial effort should be made in delineating the signaling
mechanisms contributing to complex interrelationship between
oxidative stress and inflammatory mediators to identify the specific
drug targets for controlling progressive chagasic cardiomyopathy.
The finding of a significant correlation between the increase in
MPO and LPO levels and clinical Chagas disease in this study
provide us an impetus to test and verify the sensitivity and
specificity of MPO and LPO in determining clinical Chagas
disease in large-scale cross-sectional studies. If confirmed, these
biomarkers will potentially be useful in designing predictive models
for identifying the patients at the risk of developing the clinical
disease.
Supporting Information
Figure S1 Impact of sample storage conditions on
peripheral biomarkers of inflammation, oxidative
stress and antioxidants. Sera and plasma samples from
seropositive and seronegative individuals were stored for .2 years
and subjected to two cycle of freezing and thawing. The sera (A)
and plasma (B–G) levels of MPO activity (A), AOPP contents (B),
and nitrite levels (C) were determined as markers of neutrophil/
phagocyte activation. The LPO (D) and MDA (E) contents were
determined as biomarkers of oxidative stress. The SOD activity (F)
and GSH content (G) were measured as indicators of antioxidant
status. Data (mean of triplicate observations from each sample) are
presented as box plot. The horizontal lines of the box (bottom to
top) depict the lower quartile (Q1, cuts off lowest 25% of the data),
median (Q2, middle value), and upper quartile (Q3, cuts off the
highest 25% of the data). The lower and upper whiskers depict the
smallest and largest non-outlier observations, respectively, and
solid dots represent the outliers. The spacing between the different
parts of the box indicates the degree of dispersion (spread).
Standard deviation for triplicate observations for all samples was
,12%.
(TIF)
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